ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Dronedarone

Also written as “Dabigatran etexilate plus dronedarone”, “Dronedarone (SR33589)” and “Dronedarone Hydrochloride Tablets”.

Its studies are mostly in Atrial Fibrillation · Heart Failure, led by 4 companies.

Drug pageDronedarone: every studyAll 29 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Dec 2, 200918 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sanofi140 open or runningphase 4since Dec 2, 2009Sep 13, 2005none ahead
Lunan Pharmaceutical Groupits history only20 open or runningno phasesince Jan 27, 2026Jan 27, 2026none ahead
Boehringer Ingelheimits history only10 open or runningphase 1since Feb 28, 2011Feb 28, 2011none ahead
Gilead Sciencesits history only10 open or runningphase 2since Jan 18, 2012Jan 18, 2012none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Sanofi only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 13, 2005First study: phase 3 study in Atrial FibrillationFirst studyNCT00174785 · 4,628 enrolled · United States, Argentina, Australia and more
  2. Nov 25, 20052 phase 3 studies in Atrial FibrillationNCT00259428, NCT00259376
  3. Jun 20, 2007Phase 3 study in Atrial FibrillationNCT00489736 · 504 enrolled · United States, Argentina, Australia and more
  4. Jun 12, 20082 phase 3 studiesNCT00697086, NCT00696631
  5. Dec 2, 2009Phase 4 study in Atrial FibrillationNCT01026090 · 292 enrolled · Canada
  6. Jan 12, 2010Phase 4 study in Atrial FibrillationNCT01047566 · 183 enrolled · Netherlands
  7. May 28, 2010Phase 4 study in Atrial FibrillationNCT01135017 · 112 enrolled · United States
  8. Jun 8, 2010Phase 4 study in Atrial FibrillationNCT01140581 · 402 enrolled · Australia, Austria, Estonia and more
  9. Jun 22, 2010Phase 3 study in Atrial FibrillationNCT01151137 · 3,236 enrolled · United States, Argentina, Australia and more
  10. Sep 9, 20102 phase 4 studies in Atrial FibrillationNCT01199081, NCT01198873
  11. Sep 30, 2010Phase 2 study in Atrial FibrillationNCT01213368 · 181 enrolled · Japan

TargetBeta

“Voltage-gated L-type calcium channel blocker; Sodium channel alpha subunit blocker; Inward rectifier potassium channel 2 blocker; Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker”ChEMBL 37, by rule

Studies

All 14 Sanofi leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT01213368Atrial Fibrillation · Japan2CompletedApr 2011181
NCT01199081Atrial Fibrillation · Colombia, Czech Republic, Denmark and more4CompletedApr 2012154
NCT01198873Atrial Fibrillation · United States, Canada4TerminatedJan 201276
NCT01151137Atrial Fibrillation · United States, Argentina, Australia and more3TerminatedSep 20113,236
NCT01140581Atrial Fibrillation · Australia, Austria, Estonia and more4CompletedDec 2011402
NCT01135017Atrial Fibrillation · United States4TerminatedFeb 2012112
NCT01047566Atrial Fibrillation · Netherlands4CompletedSep 2011183
NCT01026090Atrial Fibrillation · Canada4TerminatedDec 2011292
NCT00697086Atrial Fibrillation · Belgium, Czech Republic, France and more3CompletedJun 2004174
NCT00696631Heart Failure · Denmark, Hungary, Netherlands and more3TerminatedJan 2003653
NCT00489736Atrial Fibrillation · United States, Argentina, Australia and more3CompletedOct 2008504
NCT00259428Atrial Fibrillation · Belgium, Czech Republic, Denmark and more3CompletedAug 2003615
NCT00259376Atrial Fibrillation · United States, Argentina, Australia and more3CompletedSep 2003629
NCT00174785Atrial Fibrillation · United States, Argentina, Australia and more3CompletedMar 20084,628

How it is read

Names in the registry

  • “Dronedarone”, 7 entries
  • “Dabigatran etexilate plus dronedarone”, 4 entries
  • “Dronedarone (SR33589)”, 4 entries
  • “Dronedarone Hydrochloride Tablets”, 2 entries
  • “dronedarone (SR33589)”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.